Alebund Pharmaceuticals CEO outlines pipeline and global market strategy
Gavin Xia, co-founder and CEO of Chinese biotech firm Alebund Pharmaceuticals, spoke exclusively to Bloomberg about his company's product pipeline and market strategy. He outlined the firm's approach to both domestic and international markets. International expansion is presented as a key pillar of Alebund's growth strategy.
Comments
No comments yet
Comments
No comments yet โ be the first to weigh in ๐
No comments yet. Be the first!